LeMaitre Vascular

OverviewSuggest Edit

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. LeMaitre Vascular's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. 

TypePublic
Founded1983
HQBurlington, USMap
Websitelemaitre.com
Employee Ratings2.8More

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2018)457(+15%)
Revenue (FY, 2017)$100.9 M(+14%)
Share Price (Jun 2019)$26.6

Key People/Management at LeMaitre Vascular

George W. Lemaitre

George W. Lemaitre

Chairman and Chief Executive Officer
David B. Roberts

David B. Roberts

President, Board Director
Laurie A. Churchill

Laurie A. Churchill

Senior Vice President & General Counsel
Kimberly L. Cieslak

Kimberly L. Cieslak

Vice President, Marketing
Ryan H. Connelly

Ryan H. Connelly

Vice President, Research & Development
Giovanella Deiure

Giovanella Deiure

Director, Southern Europe
Show more

LeMaitre Vascular Office Locations

LeMaitre Vascular has offices in Burlington, Chandler, Fox River Grove, Melbourne and in 8 other locations
Burlington, US (HQ)
63 Second Ave
Chandler, US
2350 E Germann Rd Building 3, Suite 38
Fox River Grove, US
912 Northwest Hwy
Melbourne, AU
36 Munster Terrace
Vaughan, CA
9135 Keele St, Suite B6
Shanghai, CN
Room 809, Shangguang Xuhui Center Jin, Block No.407 YiShan Road
Show all (12)

LeMaitre Vascular Financials and Metrics

LeMaitre Vascular Revenue

LeMaitre Vascular's revenue was reported to be $100.87 m in FY, 2017
USD

Revenue (Q2, 2019)

29.5m

Gross profit (Q2, 2019)

20.3m

Gross profit margin (Q2, 2019), %

68.9%

Net income (Q2, 2019)

4.6m

EBIT (Q2, 2019)

5.9m

Market capitalization (10-Jun-2019)

523.6m

Closing stock price (10-Jun-2019)

26.6

Cash (30-Jun-2019)

13.3m
LeMaitre Vascular's current market capitalization is $523.6 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

64.5m71.1m78.4m89.2m100.9m

Revenue growth, %

10%10%14%

Cost of goods sold

19.4m22.7m24.2m26.2m30.2m31.6m

Gross profit

45.1m48.4m54.2m62.9m70.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

15.3m16.8m18.2m17.5m18.9m19.9m19.0m20.3m22.4m23.2m24.1m25.8m24.8m26.0m27.0m24.2m29.5m

Cost of goods sold

4.6m5.5m5.8m5.5m5.8m6.8m5.5m5.9m7.0m6.2m6.8m8.2m7.2m7.5m8.0m6.9m9.0m9.2m

Gross profit

10.7m11.2m12.4m12.0m13.1m13.1m13.5m14.4m15.4m17.0m17.4m17.5m17.6m18.5m19.0m17.3m20.3m

Gross profit Margin, %

70%67%68%69%69%66%71%71%69%73%72%68%71%71%70%71%69%
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

14.7m18.7m27.5m24.3m19.1m26.3m

Accounts Receivable

243.9m

Inventories

13.3m2.4m15.2m2.0m

Current Assets

41.7m48.6m58.2m59.0m80.3m94.0m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

13.6m12.5m23.5m18.4m17.0m19.4m23.6m25.9m29.3m34.7m25.8m30.1m37.5m22.8m19.6m20.1m14.8m13.3m

Inventories

13.1m14.2m15.0m16.9m16.5m15.8m15.9m17.9m17.0m17.4m20.5m

Current Assets

39.0m40.3m53.0m49.4m47.8m50.3m54.0m59.7m62.4m68.2m62.5m68.1m75.6m84.0m92.4m86.8m95.4m98.2m

PP&E

6.0m5.8m5.5m7.2m6.6m6.6m6.8m7.4m7.3m7.5m9.3m9.5m11.4m12.2m12.2m12.7m14.1m14.2m
show all
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

3.2m3.9m7.8m10.6m17.2m22.9m

Depreciation and Amortization

2.8m3.3m3.4m3.6m4.1m4.3m

Inventories

(2.2m)(2.7m)608.0k

Accounts Payable

861.0k(1.1m)2.6m(103.0k)1.5m4.3m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

2.5m(207.0k)1.1m2.0m1.4m3.1m5.2m2.2m4.8m8.0m3.2m7.9m12.9m3.9m12.6m16.9m3.5m8.1m

Depreciation and Amortization

2.0m831.0k1.6m2.4m832.0k1.7m2.5m881.0k1.8m2.7m979.0k2.0m3.0m1.0m2.1m3.1m1.3m2.6m

Inventories

(1.9m)(997.0k)(2.1m)(2.5m)(395.0k)351.0k(33.0k)(392.0k)264.0k(216.0k)(1.1m)(767.0k)

Accounts Payable

273.0k(1.8m)(1.2m)(304.0k)(1.1m)(418.0k)214.0k(1.8m)(882.0k)1.2m(367.0k)(550.0k)787.0k(2.1m)(82.0k)(345.0k)(3.5m)(4.1m)
show all
USDY, 2019

Financial Leverage

1.2 x
Show all financial metrics

LeMaitre Vascular Online and Social Media Presence

LeMaitre Vascular's Trends

Embed Graph

LeMaitre Vascular News and Updates

July 30, 2019

LeMaitre Vascular to Present at the Canaccord Genuity Annual Growth Conference on Thursday, August 8, 2019

BURLINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019 at the InterContinental Hotel in Boston, MA.
July 11, 2019

LeMaitre Vascular Will Announce Second Quarter 2019 Earnings Results on July 24, 2019

BURLINGTON, Mass., July 11, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2019 financial results on Wednesday, July 24, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to…
May 29, 2019

LeMaitre Vascular to Present at the Jefferies Healthcare Conference on Thursday, June 6, 2019

BURLINGTON, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Thursday, June 6, 2019 at the Grand Hyatt Hotel in New York City.
May 01, 2019

LeMaitre Vascular Announces Q1 2019 Financial Results

BURLINGTON, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2019 results, provided guidance, and announced a $0.085/share dividend.
February 19, 2019

LeMaitre Vascular Announces Q4 2018 Financial Results

BURLINGTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2018 results, provided guidance, announced a 21% dividend increase to $0.085/share and announced a share repurchase program.
February 06, 2019

LeMaitre Vascular Will Announce Fourth Quarter 2018 Earnings Results on February 19, 2019

BURLINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2018 financial results on Tuesday, February 19, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day …
Show more

LeMaitre Vascular Blogs

July 24, 2019

LeMaitre Vascular Announces Q2 2019 Financial Results

BURLINGTON, Mass. , July 24, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular , Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2019 results, provided guidance, and announced a $0.085 /share dividend. Q2 2019 Results Record sales of $29.5mm, +9% (+5% organic)
January 28, 2019

Jacob Petersen

Jacob Petersen kenneth.clark@… Mon, 01/28/2019 - 14:31 Jacob Petersen Vice President, Asia-Pac Jacob Petersen has served as our Vice President, Asia-Pac since October 2018, at which time he established our Asia-Pac headquarters in Singapore. Prior to joining LeMa…
January 28, 2019

Chance Kriesel

Chance Kriesel kenneth.clark@… Mon, 01/28/2019 - 14:26 Chance Kriesel Vice President of Sales, The Americas Chance Kriesel has served as our Vice President of Sales, The Americas, since November 2018. Mr. Kriesel joined us in 2003 and has held the positions of Sa…
August 01, 2018

LeMaitre Vascular to Present at Upcoming Investor Conferences

LeMaitre Vascular to Present at Upcoming Investor Conferences Content Import Wed, 08/01/2018 - 16:17 LeMaitre Vascular to Present at Upcoming Investor Conferences August 1, 2018 at 4:15 PM EDT This release is a backfill from a News Wire General …
July 19, 2018

Q2 2018 LeMaitre Vascular, Inc. Earnings Conference Call

Q2 2018 LeMaitre Vascular, Inc. Earnings Conference Call kenneth.clark@… Thu, 07/19/2018 - 14:07 Q2 2018 LeMaitre Vascular, Inc. Earnings Conference Call Display "add to calendar" true Event Type Earnings Conference Call Event …
July 18, 2018

LeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018

LeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018 Content Import Wed, 07/18/2018 - 16:18 LeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018 July 18, 2018 at 4:15 PM EDT This release is a ba…

 LeMaitre Vascular Frequently Asked Questions

  • When was LeMaitre Vascular founded?

    LeMaitre Vascular was founded in 1983.

  • Who are LeMaitre Vascular key executives?

    LeMaitre Vascular's key executives are George W. Lemaitre, David B. Roberts and Laurie A. Churchill.

  • How many employees does LeMaitre Vascular have?

    LeMaitre Vascular has 457 employees.

  • Who are LeMaitre Vascular competitors?

    Competitors of LeMaitre Vascular include Intact Vascular, Inari Medical and Synaptive Medical.

  • Where is LeMaitre Vascular headquarters?

    LeMaitre Vascular headquarters is located at 63 Second Ave, Burlington.

  • Where are LeMaitre Vascular offices?

    LeMaitre Vascular has offices in Burlington, Chandler, Fox River Grove, Melbourne and in 8 other locations.

  • How many offices does LeMaitre Vascular have?

    LeMaitre Vascular has 12 offices.